Nanotherapeutics relieve rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-04-28

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.jconrel.2017.02.032PMID 28257989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scavenger Receptor-Mediated Targeted Treatment of Collagen-Induced Arthritis by Dextran Sulfate-Methotrexate Prodrug

  2017cited by this paper
• Novel hyaluronic acid–methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models

  2016cited by this paper
• Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model.

  2016cited by this paper
• Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.

  2016cited by this paper
• Folate-targeted nanoparticles for rheumatoid arthritis therapy.

  2016cited by this paper
• Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.

  2016cited by this paper
• Activated macrophage-targeted dextran-methotrexate/folate conjugate prevents deterioration of collagen-induced arthritis in mice.

  2016cited by this paper
• Schwere Infektionen bei Patienten mit rheumatoider Arthritis

  2015cited by this paper
• Drug-loaded gold/iron/gold plasmonic nanoparticles for magnetic targeted chemo-photothermal treatment of rheumatoid arthritis.

  2015cited by this paper
• Peptide Anchor for Folate-Targeted Liposomal Delivery.

  2015cited by this paper
• Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model

  2015cited by this paper
• Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.

  2015cited by this paper
• Temperature-responsive polymeric nanospheres containing methotrexate and gold nanoparticles: A multi-drug system for theranostic in rheumatoid arthritis.

  2015cited by this paper
• Nanomedicine delivers promising treatments for rheumatoid arthritis.

  2015cited by this paper
• Light and electron microscopic detection of inflammation-targeting liposomes encapsulating high-density colloidal gold in arthritic mice

  2014cited by this paper
• FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

  2014cited by this paper
• Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis.

  2014cited by this paper
• Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.

  2014cited by this paper
• Effect of solid nanoparticle of indomethacin on therapy for rheumatoid arthritis in adjuvant-induced arthritis rat.

  2014cited by this paper
• Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide

  2014cited by this paper
• Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages.

  2014cited by this paper
• A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis.

  2014cited by this paper
• Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles.

  2013cited by this paper
• Self-assembled dextran sulphate nanoparticles for targeting rheumatoid arthritis.

  2013cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

  2013cited by this paper
• Multifunctional nanoparticles for targeting cancer and inflammatory diseases

  2013cited by this paper
• Liposomal Targeting of Prednisolone Phosphate to Synovial Lining Macrophages during Experimental Arthritis Inhibits M1 Activation but Does Not Favor M2 Differentiation

  2013cited by this paper
• An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis.

  2013cited by this paper
• Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.

  2013cited by this paper
• Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis.

  2013cited by this paper
• Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering.

  2012cited by this paper
• Assembled nanomedicines as efficient and safe therapeutics for articular inflammation.

  2012cited by this paper
• Methotrexate: a detailed review on drug delivery and clinical aspects

  2012cited by this paper
• Effect of VIP on the balance between cytokines and master regulators of activated helper T cells

  2012cited by this paper
• Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.

  2012cited by this paper
• Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.

  2012cited by this paper
• Development of macromolecular prodrug for rheumatoid arthritis.

  2012cited by this paper
• Glucocorticoid-loaded core-cross-linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis.

  2012cited by this paper
• Neuropeptides as Pleiotropic Modulators of the Immune Response

  2011cited by this paper
• Highly efficient nanomedicines assembled via polymer-drug multiple interactions: Tissue-selective delivery carriers.

  2011cited by this paper
• Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.

  2011cited by this paper
• Designing micro- and nano-particles for treating rheumatoid arthritis

  2011cited by this paper
• Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.

  2011cited by this paper
• Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

  2011cited by this paper
• Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.

  2011cited by this paper
• Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis.

  2011cited by this paper
• Adverse effects of biologics: a network meta-analysis and Cochrane overview.

  2011cited by this paper
• Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis

  2011cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cited by this paper
• Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

  2010cited by this paper
• Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis.

  2010cited by this paper
• Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints.

  2010cited by this paper
• Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis

  2010cited by this paper
• Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.

  2010cited by this paper
• Risk factors for idiopathic orbital inflammation: a case–control study

  2010cited by this paper
• Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis.

  2010cited by this paper
• Rheumatoid arthritis

  2010cited by this paper
• State-of-the-art: rheumatoid arthritis

  2010cited by this paper
• Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases

  2010cited by this paper
• Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis

  2010cited by this paper
• Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting

  2010cited by this paper
• Effects of indomethacin‐loaded nanocapsules in experimental models of inflammation in rats

  2009cited by this paper
• Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

  2009cited by this paper
• αvβ3–Targeted nanotherapy suppresses inflammatory arthritis in mice

  2009cited by this paper
• Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

  2009cited by this paper
• Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment.

  2009cited by this paper
• Treatment of Experimental Arthritis with Stealth-Type Polymeric Nanoparticles Encapsulating Betamethasone Phosphate

  2009cited by this paper
• α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy

  2008cited by this paper
• Physicochemical characterization, in vitro, and in vivo evaluation of indomethacin-loaded nanocarriers self-assembled by amphiphilic polyphosphazene.

  2008cited by this paper
• PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.

  2008cited by this paper
• Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand.

  2008cited by this paper
• Enhanced efficacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis.

  2008cited by this paper
• Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.

  2008cited by this paper
• Selectins ligand decorated drug carriers for activated endothelial cell targeting.

  2008cited by this paper
• Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.

  2008cited by this paper
• Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

  2008cited by this paper
• Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.

  2008cited by this paper
• Enhanced efficacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis

  2008cited by this paper
• Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.

  2007cited by this paper
• Targeting selectins and selectin ligands in inflammation and cancer

  2007cited by this paper
• CD36 and macrophages in atherosclerosis.

  2007cited by this paper
• Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging.

  2007cited by this paper
• Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis.

  2007cited by this paper
• Local Delivery of Indomethacin to Arthritis-Bearing Rats through Polymeric Micelles Based on Amphiphilic Polyphosphazenes

  2007cited by this paper
• Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis

  2006cited by this paper
• Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluation.

  2006cited by this paper
• In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.

  2006cited by this paper
• Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

  2006cited by this paper
• Galectin-1: a small protein with major functions.

  2006cited by this paper
• Liposomal superoxide dismutases and their use in the treatment of experimental arthritis.

  2005cited by this paper
• Treatment of experimental arthritis with poly(d, l-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate

  2005cited by this paper
• Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages.

  2005cited by this paper
• Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes.

  2005cited by this paper
• Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.

  2004cited by this paper
• Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis

  2004cited by this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004cited by this paper
• Therapeutic strategies for rheumatoid arthritis

  2003cited by this paper
• Angiogenesis as a target in rheumatoid arthritis

  2003cited by this paper
• TRAIL-R2 (DR5) Mediates Apoptosis of Synovial Fibroblasts in Rheumatoid Arthritis1

  2003cited by this paper
• Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles

  2003cited by this paper

• Self‐Assembled Myricetin‐Arginine Conjugate Nanozymes for Targeted Suppression of Joint Inflammation and Osteoclastogenesis in Rheumatoid Arthritis

  2026cites this paper
• Sinomenine hydrochloride-loaded liposomes-exosomes membrane fusion biohybrid attenuating collagen-induced rheumatoid arthritis via NF-κB pathway.

  2026cites this paper
• Nanozymes in the field of arthritis applications: classification, mechanisms, and combination therapy

  2025cites this paper
• Research Trends and Developments in Nanomaterials for Rheumatoid Arthritis: A Comprehensive Bibliometric Analysis

  2025cites this paper
• Nanomedicine for the management of rheumatoid arthritis: current status and prospective therapeutic approaches

  2025cites this paper
• Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program.

  2025cites this paper
• Enzyme-responsive liposomes target endoplasmic reticulum stress-mediated apoptosis for rheumatoid arthritis therapy.

  2025cites this paper
• Innovative rheumatoid arthritis management using injection replacement approach via dual therapeutic effects of hyalurosomes-encapsulated luteolin and dexamethasone.

  2025cites this paper
• A COMPLETE SOJOURN ON NANOTECHNOLOGICAL ADVANCEMENTS AND NANOCARRIERS APPLICATIONS IN ARTHRITIS MANAGEMENT

  2025cites this paper
• Facile Synthesis of Polymeric Nanoprobes for Actively Targeted and High-Performance MR/CT Dual-Modal Imaging of Rheumatoid Arthritis.

  2025cites this paper
• QBD APPROACH FOR THE DEVELOPMENT OF NANOSPONGE LOADED TOPICAL GEL OF FUCOIDAN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: IN VITRO, EX-VIVO, AND IN VIVO ASSESSMENT

  2025cites this paper
• Development and Evaluation of an Innovative S-Flurbiprofen-Diethylamine Emulgel With Superior Transdermal Delivery and Analgesic Activity.

  2025cites this paper
• Pharmacokinetic and Pharmacodynamic Study of Folic Acid-Modified Chitosan–Stearic Acid Nanomicelles Loaded with Tetrandrine for Rheumatoid Arthritis

  2025cites this paper
• Unveiling the synergistic impact of cocktail nanohyalurosomes encapsulating berberine and dexamethasone in managing rheumatoid arthritis: in-vitro evaluation and biological studies

  2025cites this paper
• Macrophage Membrane‐Coated Carbon Nanozymes for Targeted Drug Delivery and NIR‐Responsive Synergistic Therapy in Rheumatoid Arthritis

  2025cites this paper
• Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment

  2024cites this paper
• The combination of hydrogels and rutin-loaded black phosphorus nanosheets treats rheumatoid arthritis

  2024cites this paper
• Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management.

  2024cites this paper
• Coassembly Nanomedicine Mediated by Intermolecular Interactions Between Methotrexate and Baricitinib for Improved Rheumatoid Arthritis Treatment.

  2024cites this paper
• Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management

  2024cites this paper
• Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis

  2024cites this paper
• A Less-is-More Strategy for Mitochondria-Targeted Photodynamic Therapy of Rheumatoid Arthritis.

  2024cites this paper
• Recent Progress in Microenvironment-Responsive Nanodrug Delivery Systems for the Targeted Treatment of Rheumatoid Arthritis.

  2024cites this paper
• Multifunctional nanoparticle-mediated combining therapy for human diseases

  2024cites this paper
• Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis

  2024cites this paper
• Hypericin emulsomes combined with hollow microneedles as a non-invasive photodynamic platform for rheumatoid arthritis treatment.

  2024cites this paper
• Nanomedicine targeted anti-inflammatory therapy to deal with the ‘crux’ of rheumatoid arthritis

  2024cites this paper
• Tofacitinib Citrate-Loaded Topical Gel for the Treatment of Rheumatoid Arthritis: Formulation and In-vitro-In-vivo Characterization.

  2024cites this paper
• A review of hyaluronic acid-based therapeutics for the treatment and management of arthritis.

  2024cites this paper
• Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery Systems.

  2024cites this paper
• Advantages of Chinese herbal medicine in treating rheumatoid arthritis: a focus on its anti-inflammatory and anti-oxidative effects

  2024cites this paper
• Preparation and Evaluation of Tetrandrine Nanocrystals to Improve Bioavailability.

  2024cites this paper
• Deep-insights: Nanoengineered gel-based localized drug delivery for arthritis management

  2024cites this paper
• Design and Development of Solid Lipid Nanoparticles of Tofacitinib Citrate for the Treatment of Rheumatoid Arthritis: A Quality by Design Approach.

  2024cites this paper
• Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation

  2024cites this paper
• Biomimetic NO Scavenging Hyaluronic Acid Nanoparticles Enable Targeted Delivery of MTX and Integrated Management of Rheumatoid Arthritis.

  2024cites this paper
• Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis

  2024cites this paper
• Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy.

  2023cites this paper
• A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis.

  2023cites this paper
• 4-Iodo-6-phenylpyrimidine (4-IPP) suppresses fibroblast-like synoviocyte- mediated inflammation and joint destruction associated with rheumatoid arthritis.

  2023cites this paper
• Nanoparticulate drug delivery systems for the treatment of rheumatoid arthritis: A comprehensive review

  2023cites this paper
• Transition Metal‐Based Therapies for Inflammatory Diseases

  2023cites this paper
• The potential role of synovial cells in the progression and treatment of osteoarthritis

  2023cites this paper
• A bibliometric and visualized analysis of nanoparticles in musculoskeletal diseases (from 2013 to 2023)

  2023cites this paper
• Synthesis of gold decorated silica nanoparticles and their photothermal properties.

  2023cites this paper
• Surface Modification of Liposomes Using Folic Acid.

  2023cites this paper
• Nanomedical approaches in the realm of rheumatoid arthritis.

  2023cites this paper
• An iota-carrageenan isolated from marine alga Agardhiella ramosissima negatively modulates the inflammatory response in arthritis conditions

  2023cites this paper
• Unlocking new dimensions in rheumatoid arthritis therapy: Harnessing the power of lipid based vesicles beyond traditional therapies

  2023cites this paper
• A multifunctional supramolecular hydrogel that rapidly binds TNF-α for efficient reduction of synovial inflammation and cartilage destruction in rheumatoid arthritis

  2023cites this paper
• Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment

  2023cites this paper
• Nano-based therapeutics for Rheumatoid arthritis: Recent patents and development.

  2023cites this paper
• NANOCARRIER POSSIBILITIES IN TREATMENT OF RHEUMATOID ARTHRITIS: A REVIEW

  2023cites this paper
• Pathophysiology to advanced intra-articular drug delivery strategies: Unravelling rheumatoid arthritis.

  2023cites this paper
• Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium

  2023cites this paper
• Surface-Decorated Nanocarrier as a Targeted Drug Delivery Cargo to Folate Receptor-Overexpressing Cells for Enhancing Anti-cancer and Anti-inflammatory Activity

  2023cites this paper
• Lycium ruthenicum Murr. anthocyanins inhibit hyperproliferation of synovial fibroblasts from rheumatoid patients and the mechanism study powered by network pharmacology.

  2023cites this paper
• Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications

  2023cites this paper
• Zein nanoparticles as oral carrier for mometasone furoate delivery

  2023cites this paper
• Recent trends in stimuli-responsive hydrogels for the management of rheumatoid arthritis

  2023cites this paper
• Steroid-loaded reconstituted high-density lipoprotein nanocarrier: A new treatment for systemic lupus erythematosus

  2023cites this paper
• Development of Tofacitinib Loaded pH-Responsive Chitosan/Mucin Based Hydrogel Microparticles: In-Vitro Characterization and Toxicological Screening

  2023cites this paper
• Emerging advances in fluorescence imaging and phototherapy of arthritis

  2023cites this paper
• New Generation smart drug delivery systems for Rheumatoid arthritis.

  2023cites this paper
• CXCR4‐Expressing Mesenchymal Stem Cells Derived Nanovesicles for Rheumatoid Arthritis Treatment

  2023cites this paper
• Ca-DEX biomineralization-inducing nuts reverse oxidative stress and bone loss in rheumatoid arthritis.

  2023cites this paper
• Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats

  2023cites this paper
• ICAM-1 targeted thermal-sensitive micelles loaded with tofacitinib for enhanced treatment of rheumatoid arthritis via microwave assistance.

  2022cites this paper
• PEPTIDYLARGININE DEIMINASE-4: MEDICO-FORMULATIVE STRATEGY TOWARDS MANAGEMENT OF RHEUMATOID ARTHRITIS.

  2022cites this paper
• Emerging nanotherapeutics alleviating rheumatoid arthritis by readjusting the seeds and soils.

  2022cites this paper
• Assessment of Analgesic and Anti-inflammatory Activity of Double-layered Diclofenac Diethylamine Transdermal Patch

  2022cites this paper
• Emerging biomimetic nanotechnology in orthopedic diseases: progress, challenges, and opportunities

  2022cites this paper
• Metal nanoparticles: a platform integrating diagnosis and therapy for rheumatoid arthritis

  2022cites this paper
• On-demand drug delivery of triptolide and celastrol by poly(lactic-co-glycolic acid) nanoparticle/triglycerol monostearate-18 hydrogel composite for rheumatoid arthritis treatment

  2022cites this paper
• Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis

  2022cites this paper
• Spatiotemporal Sonodynamic Therapy for the Treatment of Rheumatoid Arthritis Based on Z-Scheme Heterostructure Sonosensitizer of Ho-1 Inhibitor Jointed Bismuth Nanotriangle

  2022cites this paper
• Design of Targeted Flurbiprofen Biomimetic Nanoparticles for Management of Arthritis: In Vitro and In Vivo Appraisal

  2022cites this paper
• Saussurea involucrata oral liquid regulates gut microbiota and serum metabolism during alleviation of collagen‐induced arthritis in rats

  2022cites this paper
• Delivery of germacrone (GER) using macrophages-targeted polymeric nanoparticles and its application in rheumatoid arthritis

  2022cites this paper
• Polymer nanotherapeutics to correct autoimmunity.

  2022cites this paper
• Development and characterization of trans-anethole-containing solid lipid microparticles: antiinflammatory and gastroprotective effects in experimental inflammation

  2022cites this paper
• Emerging insights of peptide-based nanotherapeutics for effective management of rheumatoid arthritis.

  2022cites this paper
• Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment

  2022influential citation
• Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy

  2022cites this paper
• Chitosan-based biomaterials for the treatment of bone disorders.

  2022cites this paper
• Hyaluronic acid coated Teriflunomide (A771726) Loaded Lipid Carriers for the Oral Management of Rheumatoid Arthritis.

  2022cites this paper
• Chemo-photothermal therapeutic effect of chitosan-gelatin hydrogels containing methotrexate and melanin on a collagen-induced arthritis mouse model.

  2022cites this paper
• Radicals Scavenging MOFs Enabling Targeting Delivery of siRNA for Rheumatoid Arthritis Therapy.

  2022cites this paper
• Investigation of the effects of safranal on the experimentally created rheumatoid arthritis model in rats

  2022cites this paper
• Molecular Modeling Guided Drug Designing for the Therapeutic Treatment of Rheumatoid Arthritis

  2022cites this paper
• pH-sensitive nano-polyelectrolyte complexes with arthritic macrophage-targeting delivery of triptolide.

  2022cites this paper
• Evaluation of Liposome-Loaded Microbubbles as a Theranostic Tool in a Murine Collagen-Induced Arthritis Model

  2022cites this paper
• Protective effect of Ginsenoside Rc on the complete Freund’s adjuvant-induced rheumatoid arthritis in rats by attenuation of inflammatory mediators through inhibition NF-κB pathway

  2022cites this paper
• Transdermal delivery of triptolide–phospholipid complex to treat rheumatoid arthritis

  2021cites this paper
• Anti-arthritic activity of Tin oxide-Chitosan-Polyethylene glycol carvacrol nanoparticles against Freund’s adjuvant induced arthritic rat model via the inhibition of cyclooxygenase‑2 and prostaglandin E2

  2021cites this paper
• Biomaterial-based immunotherapeutic strategies for rheumatoid arthritis

  2021cites this paper
• Therapeutic potential of targeted‐gold nanospheres on collagen‐induced arthritis in rats

  2021cites this paper
• Identification of Candidate Genes Related to Synovial Macrophages in Rheumatoid Arthritis by Bioinformatics Analysis

  2021influential citation
• Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers

  2021cites this paper
• State-of-the-art strategies and future interventions in bone and cartilage repair for personalized regenerative therapy

  2021cites this paper